An ethical argument in support of interactions between developing world countries and pharmaceutical/biotechnology companies involved in oncology drug development.
Markman
Maurie
M
Clinical Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. mmarkman@mdanderson.org
D000970:Antineoplastic Agents; D001709:Biotechnology / Q000941:ethics*; D003906:Developing Countries; D015195:Drug Design; D004345:Drug Industry / Q000191:economics / Q000941:ethics*; D040861:Ethics, Business; D006801:Humans; D007391:International Cooperation
D000970:Antineoplastic Agents